Allergy/Asthma News

In order to better manage symptoms of atopic dermatitis, health care professionals must consider aggravating factors and systemic immunotherapy, according to a study published in the Chinese Medical Journal.

The AMA adopted new policies on broader Medicare and Medicaid health care coverage during its annual House of Delegates meeting.

The prevalence of allergic diseases continues to grow, and so does the need for clinical training — especially for physician assistants, nurse practitioners and other allied health care professionals.

The AMA announced a new policy that supports requirements for drug and device sponsors to develop diversity action plans so that women and sexual and gender minorities are adequately represented in their clinical trials.

The AMA House of Delegates adopted two new policies aiming to reform prior authorization and the burden it causes patients and physicians.

The Federal Aviation Administration Reauthorization Act of 2024 includes a call for updated rules on airplane medical kits and staff training in regard to anaphylaxis-related emergencies.

SAN DIEGO — The relative expressions of three genes associated with the airway predicted mepolizumab response among urban children with asthma, according to a study presented at the American Thoracic Society International Conference.

Abrocitinib may be an effective and well-tolerated treatment for adults with prurigo nodularis and chronic pruritus of unknown origins, according to a study.

Allergic disease affects 40% of school-aged children in Australia and 45% of food allergies among infants persist until age 10 years, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Roflumilast cream 0.15% demonstrated long-term efficacy and tolerability in adults and children aged 6 years and older with atopic dermatitis, Arcutis announced in a press release.